Srini Ramanathan
Impact in
- Virology top 5%
- HIV Research and Treatment
- Infectious Diseases top 5%
- HIV/AIDS drug development and treatment
- HIV/AIDS Research and Interventions
Papers in
- Genetics 11
- Chronic Lymphocytic Leukemia Research 11
-
- PI3K/AKT/mTOR signaling in cancer 6
- Co-authors
- Kitty Yale (2 shared papers)Edwin DeJesus (2 shared papers)Huafeng Zhou (15 shared papers)Martin S. Rhee (2 shared papers)Lijie Zhong (3 shared papers)Marshall W. Fordyce (2 shared papers)Christian Callebaut (1 shared paper)Daniel Berger (1 shared paper)
- Journals
- Blood (8 papers)Cancer Research (4 papers)Journal of Clinical Oncology (3 papers)The Journal of Clinical Pharmacology (3 papers)Cancer Chemotherapy and Pharmacology (2 papers)
- Partner nations
- United StatesUnited Kingdom
In The Last Decade
Srini Ramanathan
34 papers receiving 824 citations
Peers
Comparison fields: 5 of 67
- Virology 136
- Infectious Diseases 350
- Genetics 109
- Epidemiology 302
- Emergency Medicine 61
Countries citing papers authored by Srini Ramanathan
This map shows the geographic impact of Srini Ramanathan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Srini Ramanathan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Srini Ramanathan more than expected).
Fields of papers citing papers by Srini Ramanathan
This network shows the impact of papers produced by Srini Ramanathan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Srini Ramanathan. The network helps show where Srini Ramanathan may publish in the future.
Co-authors
The 25 scholars most cited alongside Srini Ramanathan, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 34 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2014 | 257 | |
| 2 | 2013 | 249 | |
| 3 | 2013 | 61 | |
| 4 | 2015 | 43 | |
| 5 | 2013 | 24 | |
| 6 | 2015 | 24 | |
| 7 | 2021 | 19 | |
| 8 | 2016 | 19 | |
| 9 | 2013 | 16 | |
| 10 | 2015 | 12 | |
| 11 | 2015 | 11 | |
| 12 | 2016 | 10 | |
| 13 | 2022 | 9 | |
| 14 | 2015 | 9 | |
| 15 | 2013 | 8 | |
| 16 | 2015 | 7 | |
| 17 | 2014 | 7 | |
| 18 | 2013 | 7 | |
| 19 | 2013 | 6 | |
| 20 | 2013 | 5 |
About Srini Ramanathan
Srini Ramanathan is a scholar working on Genetics, Molecular Biology, Infectious Diseases, Public Health, Environmental and Occupational Health and Hematology, having authored 34 papers that have together received 843 indexed citations. Recurring topics across this work include Chronic Lymphocytic Leukemia Research (11 papers), HIV/AIDS drug development and treatment (6 papers), PI3K/AKT/mTOR signaling in cancer (6 papers), Chronic Myeloid Leukemia Treatments (5 papers), Acute Lymphoblastic Leukemia research (5 papers), Gout, Hyperuricemia, Uric Acid (3 papers), Pharmacogenetics and Drug Metabolism (3 papers) and Ophthalmology and Eye Disorders (2 papers). The work is most often cited by research in Virology (136 citations), Infectious Diseases (350 citations), Genetics (109 citations), Epidemiology (302 citations) and Emergency Medicine (61 citations). Srini Ramanathan has collaborated with scholars based in United States and United Kingdom. Frequent co-authors include Kitty Yale, Edwin DeJesus, Huafeng Zhou, Martin S. Rhee, Lijie Zhong, Marshall W. Fordyce, Christian Callebaut, Daniel Berger, U. Fritz Bredeek and Peter Ruane. Their work appears in journals such as Blood, Cancer Research, Journal of Clinical Oncology, The Journal of Clinical Pharmacology and Cancer Chemotherapy and Pharmacology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.